Popular obesity drugs could be sold in pill form as soon as next year
Pharmaceutical giants Novo Nordisk and Eli Lilly are projecting that pill versions of their coveted weight loss medications could come to market as soon as next year, increasing treatment options for obesity.
Novo’s semaglutide and Lilly’s orforglipron pills are both in stage three of clinical trials and have shown promising results. Both pills function similarly to the injection-based products Ozempic, Wegovy, Mounjaro, and Zepbound, mimicking the GLP-1 hormone that makes people feel full.
November 20, 2023 05:34 PM
November 20, 2023 05:34 PM
